Fingerprint Dive into the research topics of 'Efficacy and safety of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 24-weeks: A multicenter, randomized, double-blind, parallel-group, placebo controlled trial'. Together they form a unique fingerprint.